Logo

Marc Eloit, Frederic Laurent, Olivier Lortholary, Robin Patel, Etienne Ruppé

Nov 20, 2017

PathoQuest has formed a scientific advisory board, comprising Marc Eloit, Frederic Laurent, Olivier Lortholary, Robin Patel, and Etienne Ruppé. Eloit is the founder of PatholQuest, a principal investigator at Institut Pasteur, and a professor of virology and former head of the virology unit at the Veterinary School of Maisons-Alfort. 

Laurent is a professor of microbiology at Hospices Civils de Lyon, while Lortholary is a professor and chair of the department of infectious and tropical diseases at  Hôpital Necker-Enfants Malades. Patel is chair of the division of clinical microbiology at the Mayo Clinic, and Ruppé is an assistant professor at the Hôpital Bichat. 

The SAB will advise PathoQuest on high-value medical applications for the firm's iDTECT Blood, an NGS-based metagenomic infectious disase diagnostic technology, it said. 

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.